eISSN: 2345-6558

Free Access

Journal of Parathyroid Disease 2017;5(2):32-37 doi: 10.15171/jpd.2017.02
Relationship of circulating levels of 25(OH) vitamin D with parathyroid hormone in Iranian patients with chronic kidney disease not yet on dialysis; what is the best threshold for 25(OH) vitamin D

Original

Farrokhlaga Ahmadi 1,2 * , Zahra Mohebbi 1,2, Mitra Mahdavi-Mazdeh 1,2, Mahboob Lessan-Pezeshki 1,2

1 Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran
2 Center of Excellence in Nephrology, Tehran University of Medical Sciences, Tehran, Iran


*Corresponding author: Professor Farrokhlagha Ahmadi,
Email: ahmadifa@tums.ac.ir


Abstract

Introduction: Mineral and bone disorders are common in patients with chronic kidney disease (CKD). Vitamin D plays an important role in calcium-phosphorus balance.

Objectives: The main aim of this investigation is to assess the relation between circulating levels of 25(OH) vitamin D and parathyroid hormone (PTH) and estimating the best threshold of vitamin D which may prevent secondary hyperparathyroidism.

Patients and Methods: This cross-sectional study was conducted between January 2014 to September 2015. Adult patients with CKD who were not on routine peritoneal dialysis or hemodialysis and did not receive any kidney transplantation, enrolled to this study. Patients who were pregnant or who were on vitamin D supplementation therapy were excluded. Basic demographic and laboratory information were measured.

Results: Around 254 patient enrolled in this study (55.1% men). The prevalence of vitamin D deficiency and insufficiency were significantly high, 12.6% and 53.9%, respectively. Serum PTH level increased significantly as circulating plasma level of 25(OH) vitamin D decreased (P = 0.003). Serum total calcium increased significantly with high levels of plasma 25(OH) vitamin D (P < 0.001) and hypercalcemia was seen in 2.8% of patients. Piecewise linear regression modeling of PTH for 25(OH) vitamin D estimated the best threshold for 25(OH) vitamin D of 13.00 ng/mL (95% CI: 2.55-23.44 ng/mL) (P = 0.015).

Conclusion: This study again confirms this fact that sufficient level of serum 25(OH) vitamin D is mandatory in patients with CKD in order to prevent secondary hyperparathyroidism. Although this study recommends level of serum 25(OH) vitamin D to be above 13 ng/mL for this purpose.



Notes

Please cite this paper as: Ahmadi F, Mohebbi Z, Mahdavi-Mazdeh M, Lessan-Pezeshki M. Relationship of circulating levels of 25(OH) vitamin D with parathyroid hormone in Iranian patients with chronic kidney disease not yet on dialysis; what is the best threshold for 25(OH) vitamin D. J Parathyr Dis. 2017;5(2):32-37.

Copyright © 2017 The Author(s); Published by Nickan Research Institute. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Comments
First name  
Last name  
Email address  
Comments  
Security code



Article
PDF


Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks

Cite by
Google Scholar

Google Scholar
Articles by Farrokhlaga Ahmadi
Articles by Zahra Mohebbi
Articles by Mitra Mahdavi-Mazdeh
Articles by Mahboob Lessan-Pezeshki
Similar articles
Related articles

PubMed
Articles by Farrokhlaga Ahmadi
Articles by Zahra Mohebbi
Articles by Mitra Mahdavi-Mazdeh
Articles by Mahboob Lessan-Pezeshki


Article Access Statistics
Viewed
PDF Downloaded
Comments

Share this article!
Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 The Author(s)
Published by Nickan Research Institute